Cover Image

Induced Overexpression of THAP11 in Human Fibroblast Cells Enhances Expression of Key Pluripotency Genes

Saeid Ziaei, Mostafa Rezaei-Tavirani, Abdolreza Ardeshirylajimi, Ehsan Arefian, Masoud Soleimani

Background: THAP11 is a recently discovered pluripotency factor and described as an important gene that involved in embryonic stem cells self-renewal and embryo development, which works independently with other known pluripotency factors. We aimed to overexpressed the THAP11 gene in primary fibroblast cells to determine the effects of the THAP11 on these cells. Materials and Methods: The THAP11 gene was amplified using PCR followed by ligation into pCDH vector and lentiviral particle production in HEK293T cells by using psPAX2 and pMD2.G helper vectors. The human fibroblast cells were transduced using viral particles and after confirmation overexpression, the key pluripotency factors were estimated using real-time PCR and changes in proliferation rate was measured by the 3-[4, 5-dimethylthiazol-2-yl]-2, 5 diphenyltetrazolium bromide (MTT) test. Results: The overexpression of THAP11 in fibroblast cells leads to increase the expression level of Sox2, Oct4, Nanog and Klf4 as key pluripotency genes and a decrease in proliferation rate according to MTT results. Conclusion: Our results confirm that we are faced with a molecule with double features, which could be involved in pluripotency and proliferation suppressor simultaneously. It seems that the roles of THAP11 in pluripotency are so complex and attributed to other regulatory molecules. [GMJ.2019;8:e1308]

Cell Differentiation; Stem Cells; THAP11 Protein

Ohtsuka S, Dalton S. Molecular and biological properties of pluripotent embryonic stem cells. Gene Ther. 2008;15(2):74-81.


Holland AM, Stanley EG. Stems Cells and The Price of Immortality. Stem Cell Res. 2009;2(1):26-8.


Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9(6):702-12.


Reubinoff BE, Pera MF, Fong C-Y, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol. 2000;18(4):399.


Wilson KD, Wu JC. Induced pluripotent stem cells. JAMA. 2015;313(16):1613-4.


Zaehres H, Kim JB, Schöler HR. Induced pluripotent stem cells. Methods Enzymol. Elsevier; 2010. p. 309-25.

Sun N, Panetta NJ, Gupta DM, Wilson KD, Lee A, Jia F et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci. 2009;106(37):15720-5.

PMid:19805220 PMCid:PMC2739869

Lyssiotis CA, Foreman RK, Staerk J, Garcia M, Mathur D, Markoulaki S et al. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci. 2009;106(22):8912-7.

PMid:19447925 PMCid:PMC2690053

Dejosez M, Krumenacker JS, Zitur LJ, Passeri M, Chu L-F, Songyang Z et al. Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells. Cell. 2008;133(7):1162-74.

PMid:18585351 PMCid:PMC2495776

Zhu CY, Li CY, Li Y, Zhan YQ, Li YH, Xu CW et al. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc. Cell Death Differ. 2009;16(3):395-405. doi:10.1038/cdd.2008.160.


Yokota D, Nakamura S, Takemura T, Hirano I, Ono T, Shigeno K et al. Abstract 5060: Downregulation of THAP11 by Bcr-Abl promotes CML cell proliferation through c-Myc expression. Cancer Res. 2010;70(8 Supplement):5060-. doi:10.1158/1538-7445.am10-5060.

Parker, James B., "Characterization of THAP10 and THAP11 as Transcriptional Repressors in DNA Damage and Colon Cancer Progression" (2010). Publicly Accessible Penn Dissertations. 462.

Nakamura S, Yokota D, Tan L, Nagata Y, Takemura T, Hirano I et al. Down-regulation of Thanatos-associated protein 11 by BCR-ABL promotes CML cell proliferation through c-Myc expression. Int J Cancer. 2012;130(5):1046-59.


Roussigne M, Kossida S, Lavigne A-C, Clouaire T, Ecochard V, Glories A et al. The THAP domain: a novel protein motif with similarity to the DNA-binding domain of P element transposase. Trends Biochem Sci. 2003;28(2):66-9.

Vinckevicius A, Parker JB, Chakravarti D. Genomic determinants of THAP11/ZNF143/HCFC1 complex recruitment to chromatin. Mol Cell Biol. 2015;35(24):4135-46.

PMid:26416877 PMCid:PMC4648815

Vega-Avila E, Pugsley MK, editors. An overview of colorimetric assay methods used to assess survival or proliferation of mammalian cells. Proc West Pharmacol Soc; 2011.

Pfaffl M. Rest 2009 Software user guide. Qiagen, Hilden, Germany. 2009.

Muller PY, Janovjak H, Miserez AR, Dobbie Z. Short technical report processing of gene expression data generated by quantitative real-time RT-PCR. BioTechniques. 2002;32(6):1372-9.

Huang G, Ye S, Zhou X, Liu D, Ying Q-L. Molecular basis of embryonic stem cell self-renewal: from signaling pathways to pluripotency network. Cell Mol Life Sci. 2015;72(9):1741-57.

PMid:25595304 PMCid:PMC4809369

Zwaka TP, Dejosez M, Zitur LJ, Krumenacker J. Ronin is Essential for Perpetuity of Mouse ES Cells, and Acts Independently of Canonical Pathways. Google Patents; 2009.

Kong X-Z, Yin R-H, Ning H-M, Zheng W-W, Dong X-M, Yang Y et al. Effects of THAP11 on erythroid differentiation and megakaryocytic differentiation of K562 cells. PLoS One. 2014;9(3):e91557.

PMid:24637716 PMCid:PMC3956667

Achilleos A, Tong X, Poché RA. A new role of Ronin (Thap11) in the neural crest and craniofacial development in the mouse. The FASEB Journal. 2017;31(1_supplement):387.2-.2.

Yokota D, Nakamura S, Takemura T, Hirano I, Fujisawa S, Takeshita K et al. Downregulation of THAP11 by Bcr-Abl Promotes c-Myc-Mediated CML Cell Proliferation. Am Soc Hematology; 2009.

Lian W-X, Yin R-H, Kong X-Z, Zhang T, Huang X-H, Zheng W-W et al. THAP11, a novel binding protein of PCBP1, negatively regulates CD44 alternative splicing and cell invasion in a human hepatoma cell line. FEBS Lett. 2012;586(10):1431-8.


Zhu C, Li C, Li Y, Zhan Y, Li Y, Xu C et al. Cell growth suppression by thanatos-associated protein 11 (THAP11) is mediated by transcriptional downregulation of c-Myc. Cell Death Differ. 2009;16(3):395.


Kashyap V, Rezende NC, Scotland KB, Shaffer SM, Persson JL, Gudas LJ et al. Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev. 2009;18(7):1093-108.

PMid:19480567 PMCid:PMC3135180

Wei Z, Yang Y, Zhang P, Andrianakos R, Hasegawa K, Lyu J et al. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming. Stem Cells. 2009;27(12):2969-78.


Papapetrou EP, Tomishima MJ, Chambers SM, Mica Y, Reed E, Menon J et al. Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc Natl Acad Sci. 2009;106(31):12759-64.

PMid:19549847 PMCid:PMC2722286

Yamanaka S, Takahashi K, Okita K. Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2. Google Patents; 2012.

Thomson J, Yu J. Pluripotent stem cells obtained by non-viral reprogramming. Google Patents; 2010.

Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 2003;113(5):631-42.

Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 2003;113(5):643-55.

Silva J, Nichols J, Theunissen TW, Guo G, van Oosten AL, Barrandon O et al. Nanog is the gateway to the pluripotent ground state. Cell. 2009;138(4):722-37.

PMid:19703398 PMCid:PMC3437554

Rodda DJ, Chew J-L, Lim L-H, Loh Y-H, Wang B, Ng H-H et al. Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem. 2005;280(26):24731-7.